In the present study, we uncovered a novel mechanism by which EGCG, a major ingredient of green tea, attenuated atherosclerotic plaque formation by modulated system inflammation and dyslipidemia possibly in a TTC39B-dependent manner. The gene discussed is TTC39B; the disease is metabolic syndrome.